Icon
+91 94997 68112
Login Register

SESQUIENT - (100MG/2ML, 500MG/10ML)

FOSPHENYTOIN SODIUM None
100MG/2ML, 500MG/10ML
Less Than $1000 mn
None None
None None
None None
SESQUIENT is indicated: • for the treatment of generalized tonic-clonic status epilepticus in adult patients • prevention and treatment of seizures occurring during neurosurgery in adult patients • for short-term substitution for oral phenytoin in patients 2 years of age and older. SESQUIENT should be used only when oral phenytoin administration is not possible.
Yes
SESQUIENT Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.